Trending Topic

14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Kate Clair Cruden Hughes, Amy Hai Yan Chan

Asthma affects nearly 300 million people worldwide.1 Despite a notable decline in age-standardized prevalence, mortality and disability-adjusted life years over the past three decades, the burden of asthma remains high in many countries including low-middle-income countries.2 Climate change is also predicted to significantly impact asthma and other respiratory-related conditions, as rising global temperatures lead to longer pollen […]

Julie Ake, CHEST 2020 – Vaccine Candidates for COVID-19

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Nov 11th 2020

Following her presentation at CHEST 2020, entitled ‘Current Vaccine Candidates for COVID-19: Preclinical and Clinical Data’, Julie Ake (Walter Reed Army Institute of Research, Silver Spring, MD, USA) talks to touchRESPIRATORY further about vaccines in development for COVID-19.

Questions

  1. What different vaccine platforms are currently being investigated for COVID-19? (0.12)
  2. How are clinical trials being harmonised and accelerated for rapid vaccine development? (0:34)
  3. What is the current status of clinical trials for the leading candidates? (1:01)
  4. What factors make SARS-CoV-2 a good vaccine target, and what is the impact of virus mutations on vaccine development? (1:44)
  5. What are the potential risks associated with vaccine development and how are these being mitigated in current clinical trials? (2:32)

Disclosures: Jule Ake has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media.

Filmed in coverage of the CHEST 2020 Annual Meeting (Virtual).

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup